Hims & Hers Health Inc. (HIMS): What is Its Dividend Yield?

Hims & Hers Health Inc. (NYSE:HIMS) saw an upside of 1.36% to close Monday at $7.48 after adding $0.1 on the day. The 5-day average trading volume is 1,470,260 shares of the company’s common stock. It has gained $7.99 in the past week. An average of 2,058,990 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 2,686,212.

HIMS’s 1-month performance is -14.12% or -$1.23 on its low of $7.18 reached on 10/06/21. The company’s shares have touched a 52-week low of $6.71 and high of $25.40, with the stock’s rally to the 52-week high happening on 02/08/21. YTD, HIMS has lost -48.77% or -$7.12. However, the current price is down -70.55%% from the 52-week high price.

A Backdoor Way To Profit From Today’s Crypto Bull Market

In any crypto bull market, there's a lot of money to be made.

But what if we told you the best opportunities are not cryptocurrencies themselves… but instead, simply crypto stocks?

This strategy is simply and ridiculously easy.

Here are 6 ways to gain exposure to crypto outside the norm. This is arguably the safest bet you can make.


Insider Transactions

On Jun 18, 116 days have gone by since the last insider trading activity for Hims & Hers Health Inc. (HIMS). Lee Spencer (Chief Financial Officer) most recently sold 13,690 shares at $12.07 per share on Jun 18. This transaction cost the insider $165,238. Chief Executive Officer, Dudum Andrew, sold 22,142 shares at a price of $12.07 on Jun 18. Then, on Jun 18, Chief Operating Officer Baird Melissa sold 9,571 shares at a price of $12.07 per share. This transaction amounted to $115,522.

Valuation Metrics

Hims & Hers Health Inc. (HIMS) has a trailing price-to-earnings (P/E) ratio of 18.75 for the broader industry and 24.62 for the sector.HIMS stock has a beta of 0.00. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 13.00 while the price-to-book (PB) in the most recent quarter is 4.89.

Hims & Hers Health Inc.’s quick ratio for the period ended June 29 was 12.10, with the current ratio over the same period at 12.30 meaning that HIMS stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.00, while the total debt to equity was 0.00. In terms of profitability, the gross margin trailing 12 months is 77.50%.

Earnings Surprise

For the quarterly period ending June 29 this year, Hims & Hers Health Inc.’s cash and short-term investments amounted to $210.18 million. Net income and sales went up compared to those figures reported in the previous quarter. Analysts expected HIMS to announce -$0.08 per share in earnings in its latest quarter, but it posted -$0.03, representing a 62.50% surprise. EBITDA for the quarter stood at more than -$16.9 million. HIMS stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 54.65 million. Shareholders hold equity totaling $203.23 million

Technical Picture

Let’s look briefly at Hims & Hers Health Inc. (HIMS) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 11 October was 40.53% to suggest the stock is trending Neutral, with historical volatility in this time period at 28.13%.

The stock’s 5-day moving average is $7.40, reflecting a +3.31% or $0.24 change from its current price. HIMS is currently trading -15.67% above its 20-day SMA, -29.17% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -5.44% and -50.10% respectively.

Stochastic %K and %D was 18.55% and 15.14% and the average true range (ATR) pointed at 0.43. The RSI (14) points at 41.76%, while the 14-day stochastic is at 23.26% with the period’s ATR at 0.46. The stock’s 9-day MACD Oscillator is pointing at 0.03 and -0.24 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for Hims & Hers Health Inc. (NYSE: HIMS), BofA Securities launched coverage with a Neutral rating. Analysts offering their rating for HIMS stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate HIMS as a “sell,”, while 2 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 2 have offered a “buy” rating.

What is HIMS’s price target for the next 12 months?

Analysts have a consensus price target ranging from a low of $10.00 and a high of $14.00, with their median price target at $11.50. Looking at these predictions, the average price target given by analysts is for Hims & Hers Health Inc. (HIMS) stock is $11.75.


Please enter your comment!
Please enter your name here


Hot Topics

Related Videos

Related Videos

Related Articles



Download Free eBook For



100% free. stop anytime no spam